@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_head { this: np:hasAssertion dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_assertion; np:hasProvenance dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_provenance; np:hasPublicationInfo dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_publicationInfo; a np:Nanopublication . dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_assertion a np:Assertion . dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_provenance a np:Provenance . dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_publicationInfo a np:PublicationInfo . } dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_assertion { miriam-gene:8506 a ncit:C16612 . lld:C1709527 a ncit:C7057 . dgn-gda:DGNc06efc29ab6773f58657f4f1180860ba sio:SIO_000628 miriam-gene:8506, lld:C1709527; a sio:SIO_001121 . } dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_provenance { dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_assertion dcterms:description "[The Section of Hematology, Department of Pathology and Laboratory Medicine at King Faisal Specialist Hospital and Research Center has shared this experience during the last 10 years with more than 6,546 samples submitted for the analysis of different gene rearrangements, fusion gene transcripts and gene mutations including Ig heavy chain gene rearrangement for B-cell malignancies, T-cell receptor gamma chain gene rearrangement for T-cell malignancies, BCR/ABL-P210 and P190 fusion gene transcripts, for chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia, PML/RARalpha fusion gene for promyelocytic leukemia, AML1/ETO for acute myeloid leukemia AML-M2 with t8;21, CBFB/MYH11 for AML M4E0 with inv 16, BCL-2 for follicular lymphoma, and BCL-1 for mantle cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:16228048; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP797297.RADIpvXALsaE5Cp_lZVWBzEUeFG9uod0qq0944MGUBS5A130_publicationInfo { this: dcterms:created "2015-08-25T14:45:42+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }